Panagora Asset Management’s Tvardi Therapeutics TVRD Stock Holding History

Panagora Asset Management’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-14	Closed	-$7K	–	2421
2021 Q2	$7K	Buy	+14	New	+$8.87K	﹤0.01%	2386
2019 Q4	–	Sell	-13	Closed	-$9K	–	2591
2019 Q3	$9K	Hold	13	–	–	﹤0.01%	2196
2019 Q2	$10K	Hold	13	–	–	﹤0.01%	2402
2019 Q1	$9K	Sell	13 -112	-90%	-$67K	﹤0.01%	2373
2018 Q4	$58K	Buy	+125	New	+$80.6K	﹤0.01%	1931
2016 Q3	–	Sell	-42	Closed	-$7K	–	2467
2016 Q2	$7K	Hold	42	–	–	﹤0.01%	2243
2016 Q1	$9K	Hold	42	–	–	﹤0.01%	2219
2015 Q4	$26K	Buy	+42	New	+$23.1K	﹤0.01%	2111

Other funds holding TVRD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Panagora Asset Management's TVRD Position: Q3 2021 in Review

Panagora Asset Management sold out of Tvardi Therapeutics (TVRD) in Q3 2021, closing a stake of 14 shares — an estimated $7K sold.

Panagora Asset Management first reported a position in TVRD in Q4 2015 and held it in 8 quarters. The position peaked at $58K in Q4 2018. 168 funds tracked by Wall St. Rank hold TVRD as of Q3 2021.

Panagora Asset Management reported no remaining Tvardi Therapeutics position as of Q3 2021 after selling out during the quarter.
Panagora Asset Management sold 14 Tvardi Therapeutics shares in Q3 2021, an estimated $7K.
Panagora Asset Management first reported a position in Tvardi Therapeutics in Q4 2015 and held it in 8 quarters.
Panagora Asset Management's Tvardi Therapeutics position peaked at $58K in Q4 2018.
168 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.